{"transactions":[{"id":756635,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-01T20:10:22.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":123600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan (the \"2021 Plan\")) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Plan), each subject to the Reporting Person's Continuous Service through such date."}],"balance_after":123600,"derivative":{"exercise_price":0.9515,"expiration_date":"2036-05-27","underlying":"Class A Common Stock","underlying_shares":123600},"source":{"system":"sec-edgar","filing":"0001902958-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000190295826000004/ownership.xml","form_type":"4"}},{"id":1128809,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-05-30T21:55:04.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan)."}],"balance_after":50000,"derivative":{"exercise_price":0.62,"expiration_date":"2035-05-27","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-015037","document":"form4-05302025_090554.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000141588925015037/form4-05302025_090554.xml","form_type":"4"}},{"id":1327718,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T22:00:10.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":17708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $17.00 per share. There is no change to the expiration dates or the vesting schedule of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vested on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years."}],"balance_after":49037,"derivative":{"exercise_price":9.44,"expiration_date":"2032-01-02","underlying":"Class A Common Stock","underlying_shares":17708},"source":{"system":"sec-edgar","filing":"0000950170-24-137318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024137318/ownership.xml","form_type":"4"}},{"id":1327717,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T22:00:10.000Z","date":"2024-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $17.00 per share. There is no change to the expiration dates or the vesting schedule of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vested on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2032-01-02","underlying":"Class A Common Stock","underlying_shares":17708},"source":{"system":"sec-edgar","filing":"0000950170-24-137318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024137318/ownership.xml","form_type":"4"}},{"id":1327716,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T22:00:10.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options."}],"balance_after":101276,"derivative":{"exercise_price":4.11,"exercise_date":"2024-05-25","expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-24-137318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024137318/ownership.xml","form_type":"4"}},{"id":1327715,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T22:00:10.000Z","date":"2024-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options."}],"balance_after":0,"derivative":{"exercise_price":2.84,"exercise_date":"2024-05-25","expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-24-137318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024137318/ownership.xml","form_type":"4"}},{"id":1497389,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-30T20:10:04.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan)."}],"balance_after":50000,"derivative":{"exercise_price":5,"expiration_date":"2034-05-28","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-066579","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017024066579/ownership.xml","form_type":"4"}},{"id":1704035,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:09.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":17708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years."}],"balance_after":17708,"derivative":{"exercise_price":2.84,"expiration_date":"2032-01-02","underlying":"Class A Common Stock","underlying_shares":17708},"source":{"system":"sec-edgar","filing":"0000950170-23-071466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071466/ownership.xml","form_type":"4"}},{"id":1704034,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:09.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."}],"balance_after":31329,"derivative":{"exercise_price":17,"expiration_date":"2032-01-02","underlying":"Class A Common Stock","underlying_shares":17708},"source":{"system":"sec-edgar","filing":"0000950170-23-071466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071466/ownership.xml","form_type":"4"}},{"id":1704033,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:09.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":101276,"derivative":{"exercise_price":2.84,"expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-23-071466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071466/ownership.xml","form_type":"4"}},{"id":1704032,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T21:05:09.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":0,"derivative":{"exercise_price":4.11,"expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-23-071466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023071466/ownership.xml","form_type":"4"}},{"id":1874140,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-31T00:07:56.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":101276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":101276,"derivative":{"exercise_price":4.11,"expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0001209191-23-033046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000120919123033046/doc4.xml","form_type":"4"}},{"id":2252597,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T12:30:26.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":16112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":16112,"derivative":{"exercise_price":10.89,"expiration_date":"2032-05-24","underlying":"Class A Common Stock","underlying_shares":16112},"source":{"system":"sec-edgar","filing":"0000899243-22-019856","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000089924322019856/doc4.xml","form_type":"4"}},{"id":2442508,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":42705,"kind":"person","name":"Rometty Lisa Ann","position":1,"cik":"0001902958","reported_name":"Rometty Lisa Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T23:55:16.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":49037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on January 3, 2023; and 1/36th of the shares subject to the option vest monthly thereafter over the following two years."}],"balance_after":49037,"derivative":{"exercise_price":17,"expiration_date":"2032-01-03","underlying":"Class A Common Stock","underlying_shares":49037},"source":{"system":"sec-edgar","filing":"0001209191-22-001967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000120919122001967/doc4.xml","form_type":"4"}}]}